Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$221,549
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$221,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Carson William H. +$122K Director 1 filing
  2. Love Douglas +$100K PRESIDENT AND CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-07-11 Mattheakis Larry EVP & Chief Scientific Officer Grant or award +4,688 17,188
2022-07-11 Mattheakis Larry EVP & Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2022-07-11 Mattheakis Larry EVP & Chief Scientific Officer Grant or award +4,688 17,188
2022-07-11 Mattheakis Larry EVP & Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2022-02-11 Mattheakis Larry EVP & Chief Scientific Officer Grant or award +12,500 12,500
2022-02-11 Mattheakis Larry EVP & Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2021-09-30 Mattheakis Larry Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +220,000 220,000

Page 1 of 1 · 7 trades